InsidersTradesSigma
Follow the Henry Schein, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 14 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Stanley M. Bergman. The full history is openly available.
Analysts rate Henry Schein, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Henry Schein, Inc. es un proveedor global de productos y servicios de atención médica, principalmente para profesionales dentales y médicos. La empresa cotiza en NASDAQ bajo el ticker HSIC.